04:39 PM EDT, 09/24/2025 (MT Newswires) -- Jacob Chacko, Director, President and CEO, on September 22, 2025, sold 125,000 shares in Oric Pharmaceuticals ( ORIC ) for $1,349,938. Following the Form 4 filing with the SEC, Chacko has control over a total of 656,419 common shares of the company, with 656,419 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1796280/000160893625000006/xslF345X05/form4-09242025_080916.xml